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INTRODUCTION
Posttraumatic stress disorder (PTSD) is a psychiatric illness first recognized in war veterans and later more widely recognized in those who experience other traumas, including abuse or assault, traumatic injuries, and life-threatening illnesses. [1] [2] [3] Individuals with PTSD actively suffer from severe psychiatric symptoms that impair functioning, such as panic attacks when confronted with reminders of the trauma. 4 Diagnostic criteria for PTSD include an exposure to an actual or threatened death, serious injury, or sexual violence in the following ways: direct experience, witnessing, learning about traumatic events that occurred to close family or friends, or experiencing repeated or extreme exposure to aversive details of the traumatic events. Over a period of at least four weeks, individuals experience a constellation of symptoms, including intrusive symptoms (such as flashbacks, nightmares, and intrusive thoughts of the incident), avoidant behavior (avoiding situations, people, stimuli that remind them of the traumatic event), negative mood (which can include self-blame for the traumatic incident, isolation, and detachment), and alterations in arousal (including hypervigilance, exaggerated startle response, poor sleep and concentration).
According to the National Comorbidity Survey Replication, which was one of the largest epidemiological studies of mental disorders performed in the general U.S. population, the lifetime prevalence of PTSD in adults is 6.8%, and the annual prevalence is 3.5%. 5, 6 Adverse experiences in childhood are one example of events that can result in later symptoms of PTSD. Primary care patients have a high prevalence of adverse childhood experiences, leading to increased physical illness burden. 7 About 25%-30% of those who experience traumatic events such as those measured by the Adverse Childhood Experiences Study develop PTSD. 8 Although exposure to traumatic events is highly prevalent among primary care patients, and collaborative care interventions have been developed for the successful treatment of common mental disorders in primary care settings, 9, 10 there remains a need for information on the overall prevalence of PTSD across primary care settings. Understanding the rates of PTSD in primary care settings can facilitate the selection and use of standard screening tools (such as the PC-PTSD-5) 11 and also contribute to the development of clinically useful algorithms for patients with PTSD served in primary care clinics. Effective screening tools and treatment protocols for stepped-care 12 models are especially important in light of increased efforts to integrate behavioral health in primary care settings across the United States.
The present systematic review quantifies what is known about the prevalence of PTSD in primary care settings to help establish a benchmark that clinicians and researchers can use for estimating and comparing the prevalence of PTSD in any particular adult population that they are working with (both for screening and treatment purposes). While a recent review article addressed this topic, 13 to our knowledge this systematic review is the first with the scope to capture the full range of relevant studies.
METHODS Approach
A systematic review was performed using the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) method. 14 
Search Strategy
Databases searched included MEDLINE (using MeSH terms and a general search), CINAHL, Cochrane Library, PsycINFO, EMBASE, Google Scholar, and relevant book chapter bibliographies. The following search terms and strategy was used: ("traumatic stress" or PTSD or posttraumatic or "posttraumatic stress disorder" or trauma or "post traumatic" or "posttraumatic") AND ("primary care" or PCP or "patient centered medical home" or "internal medicine" or "family medicine" or "general practice" or "obstetrics and gynecology" or "ob/gyn" or "primary health care" or "primary healthcare") AND (prevalence). This search included MeSH terms PTSD, Primary Healthcare, Patient Centered Medical Home, Internal Medicine, Family Medicine, and Obstetrics and Gynecology, each of which map onto similar terms to expand the search in the MEDLINE database.
The databases were searched from January 1980, when the diagnosis of PTSD was first included in the Diagnostic and Statistical Manual of Mental Disorders (DSM-III), to January 2016 (date last searched). Authors MS and HH screened titles and abstracts, and also reviewed the full text of eligible articles. If data within any particular study were unclear, we contacted the authors for clarification.
Eligibility Criteria
In our review we have included original articles in English reporting the prevalence, including point or lifetime prevalence, of PTSD among patients seen in a primary care setting. Primary care was defined as first-contact medical care (family practice, internal medicine, obstetrics/gynecology clinics). We included articles in which the diagnosis of PTSD was ascertained from diagnostic interviews, self-report questionnaires, or medical record diagnoses.
Articles were excluded if they contained data sources that duplicated those of other articles (so as not to overrepresent any particular primary care population), if the topic was found not to be directly relevant, if the study was not primary carebased, or if the population studied was not representative of the entire primary care population at the study site(s). We also excluded abstracts, case reports/case series, and review articles.
Study Records
Initial titles were screened by one author (MS), and selected abstracts were screened by two independent reviewers/authors (MS and HH). Studies were selected for inclusion if two authors agreed that they clearly met eligibility criteria. The prevalence of PTSD was the main outcome of interest and was examined based on different subgroups, including general primary care, veterans in primary care, and special-risk populations in primary care (e.g., refugees and immigrants). Additional outcomes of interest included type of diagnostic or screening tool used and sample characteristics. The diagnostic or screening tools were important to better understand potential differences in PTSD prevalence, and the sample characteristics were important to examine potential trends in various prevalence levels (e.g., elevated rates of PTSD in primary care veteran populations).
The extracted data from each study was collected into a data-collection spreadsheet accessible to both authors involved in this process (MS and HH). Abstracted data included primary care population sample characteristics (location, clinic site, urban/rural, mean age, population type, sex, race, study design, and number of participants in the sample) and results (PTSD prevalence, PTSD ascertainment tool, mean questionnaire scores and cutoff scores [if relevant], time period of symptoms measured, and number of participants who completed PTSD assessment).
Risk of Bias
Articles were assessed for risk of bias using an adapted riskof-bias screen developed by Hoy and colleagues, 15 which has been used in other systematic review articles. 16 The Hoy bias tool was modified to screen for bias based on the studies' representation of a primary care sample rather than a national population. Articles were ranked for risk of bias by two authors (MS and HH) independently. Articles were assigned a low, medium, or high risk of bias, with 9 representing little risk of bias and 0 representing high risk of bias. Low risk of bias was assigned if the article contained 7-9 items on the risk-ofbias screen, moderate risk if the article contained 3-6 items, and high risk if the article contained 0-2 items. The risk-ofbias information is presented in the results section below, with comments regarding any trends in bias scores and prevalences.
Because of the diversity of primary care, quantitative synthesis was not appropriate for this systematic review. Median PTSD prevalence was calculated using a median calculator in order to summarize the data.
RESULTS
Of 10,614 titles screened, 89 full-text articles were assessed for eligibility. Forty-one studies were included in the qualitative synthesis (see Supplemental Figure 1 , available online at http://links.lww.com/HRP/A55). General sample characteristics are described in Supplemental Table 1 (available online at http://links.lww.com/HRP/A54). Results are presented in Table 1 . Studies were conducted in the following countries: Canada (1), Israel (2), Italy (1), Lithuania (1), Puerto Rico (1), Qatar (1), South Africa (2), Spain (1), Sweden (1), Switzerland (1), and the United States (29) . Study designs included 30 crosssectional studies and 11 retrospective reviews of the medical records.
The point prevalence of PTSD diagnosis ascertained by diagnostic interviews (e.g., Structured Clinical Interview, Diagnostic Interview Schedule, Composite International Diagnostic Interview, Mini-international Neuropsychological Interview, Clinician-Administered PTSD Scale) ranged from 2% to 32.5% (17 studies). 18, 20, [23] [24] [25] 28, [30] [31] [32] 35, 37, 39, 41, [43] [44] [45] 57 The point prevalence of substantial PTSD/clinically important PTSD symptoms based on questionnaire thresholds ranged from 2.9% to 39.1% (15 studies). 17, 19, 21, 22, 26, 27, 29, 33, 34, 36, 38, 40, 42, 46, 52 The overall median point prevalence of PTSD in primary care samples was 12.5% (civilian population median [n = 21] = 11.1%; special-risk population median [n = 3] = 12.5%; veteran median [n = 7] = 24.5%).
The prevalence of PTSD in administrative data-based studies ranged from 3.5% to 29.2% (10 studies). 25, [47] [48] [49] [50] [51] [53] [54] [55] [56] Finally, the lifetime prevalence of PTSD diagnosis based on diagnostic interviews ranged from 14.5% to 48.8% (6 studies). 18, 20, 23, 25, 44, 57 Several potential risk factors for PTSD in primary care populations were identified. In studies reporting separate results for PTSD point prevalence for men and women, women were more likely to have PTSD in civilian populations, 20, 31 whereas men were more likely to have lifetime PTSD in one veteran population. 51 Populations with known prior exposure to violence generally had higher rates of PTSD than those without prior exposure to violence. 38 The PTSD Checklist (6 studies) 17, 22, 26, 38, 46, 52 and the Composite International Diagnostic Interview (6 studies) 20, 23, 25, 30, 37, 44 were the diagnostic tools most often used. The former is a screening measure, whereas the latter is a structured clinical diagnostic interview. Risk of bias in all studies remained medium to low (reported individually in Supplemental Table 1 , http://links.lww.com/HRP/A54). Trends in a possible relationship between bias scores and prevalences were not apparent.
DISCUSSION
This systematic review highlights several key features of PTSD in primary care settings. First, the point prevalence of PTSD was much higher than the one-year general population prevalence of PTSD found by the National Comorbidity Survey Replication, 6 indicating that primary care is an especially important setting in which to identify and manage PTSD.
Additionally, the prevalences of PTSD in the included studies varied widely, similar to what was found by Greene and colleagues, 13 who noted that the heterogeneity apparent in their findings was a result of "samples with different levels of trauma exposure." 13 Another reason for this heterogeneity may be that populations could have trauma exposure but have sufficient protective factors (e.g., secure attachment relationships to process the traumatic experiences), [60] [61] [62] thus mitigating the risk for developing PTSD symptoms. Additionally, many people who experience trauma and suffer from mental health effects of trauma (e.g., as in chronic childhood abuse or ongoing domestic violence) do not fit the criteria for PTSD. 1 Our findings suggest that level of trauma exposure specific to the diagnosis of PTSD is likely one factor contributing to this heterogeneity, as studies of veterans generally had higher PTSD reported (median = 24.5%) than those of civilians (median = 11.1%) or special-risk (refugee/immigrant) primary care samples (median = 12.5%). We additionally identified several reasons that may account for this range, including varying methods of case ascertainment (e.g., various scales with different cutoff scores, structured interviews, and chart reviews) or unmeasured differences between study populations (e.g. location, age, other untracked demographic factors, or selection factors [patient refusal rates, random versus consecutive sampling]).
Specific risk factors identified for various populations include women being more likely to have PTSD in civilian populations. This finding might suggest that women experience more trauma than men in civilian populations (e.g., as victims of domestic violence that does result in PTSD) or have less access to protective factors. Men were found to have a higher lifetime prevalence of PTSD in one large population study of veterans; the timeframe of PTSD symptoms might therefore be important to consider (e.g. veterans may return from Table 1 PTSD Prevalence in Primary Care Populations Table 1 Continued combat without expressing PTSD symptoms, which may develop later in life). It makes intuitive sense that populations with known prior exposure to violence were generally found to have higher PTSD prevalence.
We assessed for meaningful differences of methodology and found that studies using diagnostic interviews exhibited similar ranges to studies identifying PTSD using thresholds on self-report questionnaires. This similarity suggests that the two forms of diagnosis might be similarly effective in identifying PTSD. Median PTSD prevalence was calculated to summarize the data, with the caveat that individual primary care clinics may be best served to find studies examining populations with characteristics similar to themselves in order to estimate their particular PTSD prevalences.
The findings reveal that, although primary care PTSD prevalence reports vary greatly, PTSD in this setting is common (regardless of the type of population [e.g., civilians versus veterans]), with the median prevalence approximating that of depression. 63, 64 Given the growing understanding of mental and physical adverse effects of traumatic stress, 7, 65, 66 it is important that in managing PTSD, primary care settings use a standard screening tool for PTSD and then develop clear and feasible clinical guidelines based on the available evidence. A systematic review of PTSD interventions in medical settings is needed to help further our understanding of evidence-based PTSD management.
Although guidelines for depression treatment in primary care settings have been developed, relatively few guidelines have been designed to address the management of PTSD in primary care. In the United States a pragmatic treatment algorithm has been developed, with guidelines specifically for the pharmacological treatment of PTSD; 67 although based on a literature review and the experience within one practice setting, the algorithm is not a primary care-based program and has not been tested in primary care or for use by nonmental health specialists.
The collaborative care model or other primary care interventions may have the potential to address the treatment needs of those with PTSD in primary care settings. The effectiveness of collaborative care treatment for depression in primary care is well established. 68, 69 Some preliminary evidence, including three randomized, controlled trials, suggests that collaborative care may be an effective intervention for PTSD in primary care; 10, [70] [71] [72] [73] and some additional evidence suggests that other interventions in primary care may be at least as effective as collaborative care, and perhaps even more effective. 74, 75 One randomized, controlled trial found that patients who attended eight sessions of cognitive-processing therapy in addition to usual care by a primary care clinician had equal improvement to patients who received extensive telemedicine collaborative-care interventions. 70 This finding might reflect that patients who are able to participate in at least eight offered therapy sessions are a self-selecting group who are, compared to those who did not complete this number of sessions, better able or more determined to complete Table 1 Continued the available treatment, or it might indicate that therapy is the mainstay of treatment for PTSD. Another randomized, controlled trial found that patients receiving a "minimally enhanced usual care intervention" consisting of primary care clinician education about "trauma, PTSD, and evidencebased psychopharmacology" experienced greater improvement than those receiving a more traditional, resource-intensive, collaborative-care intervention. 75 This surprising finding may indicate that treatment with a provider whom the patient is comfortable and has an already-established relationship is more successful than more-intensive treatment with a new team, and suggests that psychoeducation and medication education for primary care physicians may be a cost-effective method of treating patients with PTSD. However, decreased PTSD symptoms were noted for all groups in the study, and improvements in the "minimally enhanced usual care" group were not overwhelmingly different than the collaborativecare group. 75 It seems that attention to this diagnosis is likely helpful, and that researchers have yet to determine the specific clinical treatment that works best. Given the high prevalence of PTSD in primary care and the lack of specialty mental health providers to adequately manage PTSD, more studies of collaborative care, its variations, and other interventions for this condition in primary care settings are needed to better understand how to optimally meet the needs of this population. Trauma expert Judy Herman offers the following general guideline: "The core experiences of psychological trauma are disempowerment and disconnection. Recovery, therefore, is based upon the empowerment of the survivor and the creation of new connections. Recovery can take place only within the context of relationships; it cannot occur in isolation." 1(p 133) Researchers and clinicians may need to shift from focusing on individual patient treatment to facilitating greater psychological connections for these patients.
Neglecting mental health treatment for this population may make common medical conditions more difficult to manage. For instance, the original Adverse Childhood Experiences Study showed a direct relationship between high numbers of adverse childhood experiences and increased risks for liver disease, ischemic heart disease, cancer, chronic lung disease, and skeletal fractures. 7 While adverse events do not always result in PTSD, the Adverse Childhood Experiences Study does make clear that emotional adversity correlates with long-term physical illness. A recent study showed that women with PTSD have nearly twice the likelihood of developing type 2 diabetes. 65 Furthermore, women with increased PTSD symptom severity were found to have a 104% increase in health care costs versus women with low severity of PTSD symptoms and those with no symptoms. 66 Although no studies of interventions for PTSD treatment have shown a decrease in the burden of physical disease, the collaborative-care literature points to the benefit of addressing physical comorbidities along with any specific psychiatric diagnoses. The depression literature reveals that a collaborativecare intervention targeting depression, glucose control in diabetes, hypertension, and hyperlipidemia led to improvement in all outcomes. 76 The Improving Mood-Promoting Access to Collaborative Treatment trial found that geriatric patients with depressive disorders receiving the collaborative-care intervention had improved physical functioning 77 and had reduced costs associated with hospitalizations for medical illnesses. 78 In a secondary analysis of the Communication and Low Mood trial, the authors reported that treatment of anxiety improved self-reported physical functioning as measured by the 12-item Short Form Survey (included here with the caveat that outcome assessment was manipulated in order to yield a significant finding). 79 Primary care providers have the capacity to fill the gap between mental health need and mental health care availability. 75 Primary care providers can use a screening tool such as the PTSD Checklist-Civilian Version (17 questions) or the Primary Care PTSD Screen (4 questions) (both with >80% sensitivity and specificity) 31 to help identify possible PTSD in patients presenting with symptoms of anxiety or depression who have a history of trauma exposure. Following a positive PTSD screen and warranted diagnostic assessment to confirm a positive screen, primary care providers can prescribe prazosin for nightmares, serotonin reuptake inhibitors (paroxetine and sertraline are the only medications that approved by the Food and Drug Administration for PTSD treatment) or venlafaxine as evidence-based options for treating PTSD, and refer for appropriate therapy if the patient is agreeable to that intervention. 67 Additionally, the United Kingdom National Institute for Health and Clinical Excellence PTSD guidelines suggest trauma-focused psychological therapy, prior to the prescription of medications, for all who screen positive for PTSD. 8 Access to these therapies likely varies greatly between primary care clinical sites. Mental health providers are increasingly integrated into primary care sites and can be part of a "stepped care" model for patients who do not respond to initial interventions offered by primary care clinicians. 80 Future studies should consider using a standardized screening tool, such as the Primary Care PTSD Screen, which is used in Veterans Administration health care.
This review has several limitations. Despite efforts to comprehensively review multiple databases, relevant articles may have been missed due to inconsistent indexing in electronic databases. Articles not written in English were excluded due to difficulties accessing or translating findings, further increasing the risk of missing relevant articles and making this review more applicable to populations served by Englishspeaking clinicians. Included studies had varying designs and therefore multiple methodological limitations. Ranges and medians of PTSD prevalence, rather than means, are reported because of the great variation in study designs, which limits the generalizability of findings. Therefore, clinicians may be best served by reviewing the studies included here that have similar demographics to those at their practice sites. The major strength of this study is the extensiveness of the search methodology. While the study mentioned above by Greene and colleagues 13 had a similar focus to the present study, ours is significantly more systematic in that it includes not just two databases but five, uses MeSH terms to include more in the search results, and has a longer overall timeframe.
CONCLUSION
This systematic review determined that the point prevalence of PTSD in primary care settings varies greatly, ranging from 2% to 39.1%, but with a median point prevalence of 12.5%, similar to that of depression. Establishing a median prevalence is important for those working with primary care populations as they will be able to compare their local prevalence to what might be expected in similar settings, and target screening or treatment interventions accordingly. Given the public health costs of PTSD, additional research is needed to examine and explore optimal management of PTSD in primary care settings.
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